MBRX Stock, Moleculin Biotech Inc. Information
Stock Information
Get MBRX Alerts
News, Short Squeeze, Breakout and More Instantly...
About Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical-stage pharmaceutical company with a focus on the treatment of highly resistant cancers and viruses through the development of its drug candidates. The company has three core technologies: Annamycin which is a next-generation anthracycline; Immune/Transcription Modulators, of which WP1066 is a member; and Metabolism/Glycosylation Inhibitors, of which WP1122 is a member.